Cholangiocarcinoma: novel therapeutic targets

Area of Science:

• Oncology
• Hepatology
• Cancer Therapeutics

Background:

• Cholangiocarcinoma (CCA) is an aggressive liver cancer with poor prognosis and limited treatment options.
• CCA heterogeneity and drug resistance necessitate novel therapeutic approaches.
• Early diagnosis of CCA remains a significant clinical challenge.

Purpose of the Study:

• To review current and emerging therapeutic strategies for cholangiocarcinoma (CCA).
• To explore novel drug targets and therapeutic tools for managing CCA.
• To highlight the potential of targeting the tumor microenvironment in CCA treatment.

Main Methods:

• Literature search of PubMed using keywords: 'cholangiocarcinoma', 'miRNA', 'FGFR', 'immunotherapy', 'microenvironment'.
• Focused on papers published between 2015 and 2019.
• Review of preclinical studies and expert opinions on CCA treatment.

Main Results:

• Preclinical studies show promise in targeting specific cells and pathways in CCA.
• The tumor microenvironment, including hepatic cell coordination, is identified as a potential therapeutic target.
• Emerging tools like extracellular vesicles demonstrate potential for CCA management.

Conclusions:

• Novel therapeutic strategies are crucial for overcoming CCA drug resistance.
• Targeting the tumor microenvironment presents a promising avenue for CCA treatment.
• Extracellular vesicles offer a potential new modality for managing CCA and its associated microenvironment.